OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Social Drivers of Cancer Risk and Outcomes Among African American Men	111
PET Imaging of Metabolism, Perfusion, and Hypoxia	47
Oncology Physician Workforce Diversity	27
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	23
Toxicities From Antibody-Drug Conjugates	23
Clinical Evidence Generation During a Pandemic	22
Building a Bridge to Equity in Health and Health Care in Cancer Care	22
Health Care Policy and Disparities in Health	20
Stereotactic Body Radiation Therapy	19
Melanoma—Modern Treatment for Metastatic Melanoma	18
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	18
Nonoperative Management for Rectal Cancer	18
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	17
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	16
Metastatic Melanoma Treatment in Special Populations	14
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	14
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	14
Diversity in Cancer Care	13
Germline Predisposition to Myelodysplastic Syndromes	13
Primary Prevention of Cancer	12
Prostate Cancer, Race, and Health Disparity	12
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	12
Rectal Cancer—The Only Constant Is Change	12
Antibody Drug Conjugates in Multiple Myeloma	12
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	12

How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	11
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	10
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	10
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	10
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	10
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	10
Supportive Care for Patients With Myelodysplastic Syndromes	9
New Metabolomic Insights Into Cancer	9
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	9
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	9
Updates in the Management of Uveal Melanoma	9
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	8
Discovery of Natural Products for Cancer Prevention	8
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	8
Introduction	8
Impact of Precision Medicine in Oncology	8
Menopausal Hormone Therapy and Breast Cancer	8
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	7
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	7
Hormone Replacement Therapy After Breast Cancer	7
Telehealth and Technology	7
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	7
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	7
How Far We’ve Come	7
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	7
Role of the Microbiome in Immunotherapy of Melanoma	7
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	7